Key result
Severe COPD exacerbations linked to ~6.4-fold higher odds of major cardiovascular events.
Why the study?
COPD patients commonly present with CVD, but the association between COPD exacerbations and major CV events in patients with prior CVD required investigation.
Are acute moderate and severe COPD exacerbations associated with an increased risk of major cardiovascular events in COPD patients with a history of stable cardiovascular disease?
Cohort (n=1,501)
Yes
Are acute moderate and severe COPD exacerbations associated with an increased risk of major cardiovascular events in COPD patients with a history of stable cardiovascular disease?
Severe COPD exacerbations are strongly associated with a 6.4-fold increased odds of major cardiovascular events—primarily occurring within 30 days post-exacerbation—underscoring the need to optimize COPD maintenance therapy to prevent cardiopulmonary decompensation.
Answers are grounded in this paper and cite their sources.
May warrant closer post-exacerbation CV monitoring in high-risk COPD; extends prior observational data but leaves causal inference open.
Objective: Patients with chronic obstructive pulmonary disease (COPD) commonly present with cardiovascular disease (CVD). We investigated the association between COPD exacerbations and major cardiovascular (CV) events in a COPD population with a history of CVD. Methods: This population-based and register-based cohort study identified all Danish COPD patients aged ≥40 years who visited a hospital-based, pulmonary outpatient clinic for COPD between 1st January, 2010, and 31st December, 2016, from a nationwide COPD registry. Patients with a history of a major CV event 36‒6 months prior to their COPD measurement date and no CV event 6 months before this date were included. During a 6-month assessment period, the risks of a new CV event (hospitalization with fatal/non-fatal stroke, myocardial infarction, or heart failure) and moderate and severe COPD exacerbations were evaluated. Odds ratios with 95% confidence intervals for CV events and death were estimated using adjusted logistic regression models. Results: Of the 1501 COPD patients included, 55% experienced a COPD exacerbation and 13% experienced both an exacerbation and a CV event during follow-up (6 months). The odds of a CV event were 1.5 times higher in patients with a moderate exacerbation and more than 6-times higher in those with a severe exacerbation vs patients with no exacerbation(s). The majority of CV events occurred within 30 days post exacerbation in patients who experienced both an exacerbation and a CV event. In total, 113 patients died during the study period: 28% of deaths were caused by CVD and 72% by reasons other than CVD, mostly COPD. Conclusion: In patients with known CVD, severe COPD exacerbations are associated with increased odds of major CV events that occur within 30 days post exacerbation, highlighting the need to prevent exacerbations in COPD patients with concomitant CVD to potentially improve both respiratory and CV health.
No takes yet. Share an insight, caveat, or question.
Løkke et al. (2023) conducted a cohort in COPD with a history of stable cardiovascular disease (n=1,501). Severe COPD exacerbation vs. No COPD exacerbation was evaluated on Fatal or non-fatal major cardiovascular event (hospitalization with primary diagnosis of stroke, myocardial infarction, or heart failure) (OR 6.4, 95% CI 4.5-9.1, p=<0.0001). Severe COPD exacerbations were associated with a 6.4-fold higher odds of major cardiovascular events compared to no exacerbations.
Synapse has enriched 10 related papers. Consider them for comparative context: